Brief: Virbac Acquires Sasaeah In Japan

Orix

06/03/2024 07:33

March 6 (Reuters) - Virbac SA  VIRB.PA :
    * TO TAKE A LEADING POSITION IN JAPAN THROUGH THE
ACQUISITION OF
ORIX ANIMAL HEALTH SUBSIDIARY, SASAEAH
    * SASAEAH VALUE OF AROUND EUR 280 MLN
    * COMPLETION OF THE TRANSACTION IS NOT SUBJECT TO ANY
REGULATORY
APPROVAL; IT IS EXPECTED TO CLOSE BY THE BEGINNING OF APRIL 2024
    * THIS STRATEGIC ACQUISITION WILL BRING TO VIRBAC A
LEADERSHIP
POSITION IN FARM ANIMAL VACCINES MARKET IN JAPAN, NOTABLY IN
CATTLE SEGMENT, AND A LARGE PORTFOLIO OF PHARMACEUTICAL PRODUCTS

Source text for Eikon:  ID:nGNE3GB0GM 
Further company coverage:  VIRB.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587 785 110;))